Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Blast Crisis × troxacitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2 Recurrence 1 Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Blast Crisis 1

Interventions

Imatinib Mesylate 4 nilotinib 3 Dasatinib 3 troxacitabine 1 ponatinib 1 litronesib 1 exatecan 1 bosutinib 1 blinatumomab 1 asciminib 1 TAK-901 1 STA 9090 1 Panobinostat 1 Homoharringtonine 1 Fentanyl 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00012259 2021-06-10

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Takeda

Phase 2 Completed

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡